Share of Cost, Increased Alzheimer’s risk linked to long-term benzodiazepine use

Thursday, Mar. 5th 2015 6:00 AM

Long-term users of benzodiazepines, drugs used to treat anxiety and insomnia, may be at increased risk of developing Alzheimer’s disease, according to a new study published in the BMJ.

Mainly used to treat anxiety and insomnia, benzodiazepines are widely used in developed countries, particularly among the elderly.

The main cause of dependency in older people, dementia currently affects about 36 million people worldwide. This number is expected to double every 2 decades because of population growth, reaching an estimated 115 million in 2050

Posted on Thursday, Mar. 5th 2015 6:00 AM | by Share of Cost | in Share of Cost | Comments Off on Share of Cost, Increased Alzheimer’s risk linked to long-term benzodiazepine use